Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

$29.8B

Market Cap • 11/18/2024

1999

(25 years)
Founded

2005

(19 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

San Diego

Headquarters • California